Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

August 11, 2021

Study Completion Date

March 31, 2024

Conditions

Ovarian Cancer

Interventions

DRUG

Unesbulin

Unesbulin will be given in combination with carboplatin and paclitaxel for up to 7 cycles depending on which cohort the patient is in.

Trial Locations (1)

University of Oklahoma Health Sciences Center, Oklahoma City